David Kirn
2022
In 2022, David Kirn earned a total compensation of $3.3M as Chief Executive Officer at 4D Molecular Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $321,750 |
|---|---|
| Option Awards | $2,367,000 |
| Salary | $585,720 |
| Other | $13,500 |
| Total | $3,287,970 |
Kirn received $2.4M in option awards, accounting for 72% of the total pay in 2022.
Kirn also received $321.8K in non-equity incentive plan, $585.7K in salary and $13.5K in other compensation.
Rankings
In 2022, David Kirn's compensation ranked 1,103rd out of 5,683 executives tracked by ExecPay. In other words, Kirn earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,103 out of 5,683 | 81st |
Division Manufacturing | 526 out of 3,091 | 83rd |
Major group Chemicals And Allied Products | 192 out of 1,406 | 86th |
Industry group Drugs | 172 out of 1,307 | 87th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 295 | 87th |
Source: SEC filing on April 12, 2023.
Kirn's colleagues
We found two more compensation records of executives who worked with David Kirn at 4D Molecular Therapeutics in 2022.
News
4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
April 10, 2024
4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
April 12, 2023
4D Molecular Therapeutics CEO David Kirn's 2021 pay jumps 641% to $5.2M
April 13, 2022
4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
April 6, 2021